Citadel Advisors - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 137 filers reported holding ARRAY BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$230,767,000
+963.2%
4,980,950
+459.5%
0.10%
+854.5%
Q1 2019$21,705,000
+234.1%
890,265
+95.3%
0.01%
+175.0%
Q4 2018$6,497,000
-30.4%
455,878
-25.8%
0.00%0.0%
Q3 2018$9,337,000
-4.7%
614,272
+5.2%
0.00%
-20.0%
Q2 2018$9,796,000
-54.7%
583,792
-55.9%
0.01%
-58.3%
Q1 2018$21,613,000
+8.0%
1,324,306
-15.3%
0.01%
-7.7%
Q4 2017$20,004,000
-46.6%
1,562,885
-48.7%
0.01%
-53.6%
Q3 2017$37,446,000
+282.7%
3,044,425
+160.4%
0.03%
+250.0%
Q2 2017$9,785,000
-2.7%
1,169,078
+3.9%
0.01%
-11.1%
Q1 2017$10,057,000
+397.1%
1,124,970
+388.8%
0.01%
+200.0%
Q4 2016$2,023,000
-73.1%
230,150
-79.3%
0.00%
-57.1%
Q3 2016$7,512,000
+18.6%
1,112,865
-37.4%
0.01%0.0%
Q2 2016$6,332,000
+231.0%
1,778,761
+292.3%
0.01%
+250.0%
Q4 2015$1,913,000
+113.5%
453,393
+130.7%
0.00%
+100.0%
Q3 2015$896,000
-42.3%
196,496
-8.7%
0.00%0.0%
Q2 2015$1,553,000
-28.3%
215,282
-26.8%
0.00%
-50.0%
Q1 2015$2,167,000
+1736.4%
294,117
+1077.9%
0.00%
Q4 2014$118,000
+131.4%
24,969
+73.2%
0.00%
Q3 2014$51,000
-92.7%
14,417
-90.6%
0.00%
-100.0%
Q2 2014$703,000
+1908.6%
154,165
+1944.6%
0.00%
Q1 2014$35,000
-82.0%
7,540
-80.5%
0.00%
Q4 2013$194,000
-81.7%
38,679
-77.3%
0.00%
-100.0%
Q3 2013$1,061,000
-55.5%
170,586
-67.5%
0.00%
-50.0%
Q2 2013$2,382,000524,6990.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
Advisory Services Network, LLC 3,442$159,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ARRAY BIOPHARMA INC shareholders